🇺🇸 FDA
Pipeline program

Baloxavir Marboxil

MV40618

Phase 3 small_molecule completed

Quick answer

Baloxavir Marboxil for Influenza is a Phase 3 program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).

Program details

Company
Hoffmann-La Roche
Indication
Influenza
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials